Reclazepam

Reclazepam

Clinical data
ATC code	none
Identifiers
IUPAC name 2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one
CAS Number	76053-16-2 Y
PubChem CID	3052777
ChemSpider	2314554 Y
UNII	YJL42911RA
KEGG	D05710 Y
Chemical and physical data
Formula	C18H13Cl2N3O2
Molar mass	374.221 g/mol
3D model (JSmol)	Interactive image
SMILES Clc1ccccc1/C4=N/CCN(C\2=N\C(=O)CO/2)c3ccc(Cl)cc34
InChI InChI=1S/C18H13Cl2N3O2/c19-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)20)21-7-8-23(15)18-22-16(24)10-25-18/h1-6,9H,7-8,10H2 Y Key:MQGIGGJUPITZSE-UHFFFAOYSA-N Y
(verify)

Reclazepam^[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.^[2]

See also

• Benzodiazepine

References

1. ↑ US Patent 4208327
2. ↑ Pscyhotropics.dk (20 January 1986). "reclazepam". Retrieved 24 August 2009.